Moist Wound Dressings Market Size, Share, Growth Analysis, By Product(Foams, Hydrocolloids, Semi-Permeable Films, Hydrogels), By Application(Pressure Ulcers, Diabetic Ulcers, Burn Wounds, Surgical Wounds), By End-user(Hospitals, Homecare, Clinics, and Others), By Region - Industry Forecast 2025-2032

Global Moist Wound Dressings market size was valued at USD 4.31 billion in 2022 and is poised to grow from USD 4.53 billion in 2023 to USD 6.80 billion by 2031, growing at a CAGR of 5.2% in the forecast period (2024-2031).

Key players operating in the moist wound dressings industry are making efforts like launching new products, receiving approvals for new products, strategic acquisitions, and innovations in the product to take an edge over one another in competition. Moreover, continual growth in pharmaceutical industry and pharmaceutical sales have rewritten the ladder of the wound dressings technology development. In addition, the increase in quantity of sanitizers manufactured and the adoption of bio-based isopropyl alcohol as cleaning agents in wound care dressings are contributing to the market growth. However, providing desired purity levels for IPA in wound care products and health issues associated with various chemical components will remain important challenges for industry players to overcome.  '3M Healthcare (US)', 'Coloplast A/S (Denmark)', 'Medline Industries, Inc. (US)', 'Cardinal Health, Inc. (US)', 'B. Braun Melsungen AG (Germany)', 'Smith & Nephew PLC (UK)', 'ConvaTec Group PLC (UK)', 'Derma Sciences, Inc. (US)', 'Systagenix Wound Management Ltd (UK)', 'Mölnlycke Health Care AB (Sweden)', 'Johnson & Johnson (US)', 'Hollister Incorporated (US)', 'Ethicon, Inc. (US)', 'Acelity L.P. Inc. (US)', 'Advancis Medical (UK)', 'Coloplast Corporation (US)', 'Medtronic plc (Ireland)', 'Mölnlycke Health Care (US)', 'Urgo Medical (France)', 'Medline Industries Ltd. (UK)', 'Coloplast, in January 2024, launched a new silicone foam dressing, Biatain Silicone Fit for prevention of pressure injury and for wound management in the United States. ', 'In June 2023, JeNaCell, a subsidiary of Evonik, launched Innovative Bioengineered Cellulose Products epicite balance for treatment of chronic wounds. It is distributed to hospitals and homecare centres through Coopmed ApS. ', 'In October 2022, Healthium Medtech, a medical device and technology company, launched a new line of wound dressing products, Theruptor Novo, for the treatment and management of chronic wounds such as legs ulcers and diabetic foot ulcers.'

Improving Macroeconomic Factors and Growing Technology Adoption: Moist wound dressings market in Asia is expected to grow owing to increasing demographics and economies in emerging countries such as China, Japan, and India. In addition to this, the worldwide moist wound dressings market is expected to witness innovation in dressings and products for wound care, growing adoption of technology, and rise in the awareness of infection expected to create new opportunities within the market. 

North America is dominating with the largest moist wound dressings market share. North America has emerged as a prominent region for the market, attributed to the increasing pressure of inflation and significant participants in the market. A rise in the number of diabetes, burns, and surgeries carried out in the region has caused the number of surgical site infections (SSIs) to increase. Surgical site infection has a wide use of moist wound dressing. In order to avoid an increase in cases of surgical site infection globally, the demand for moist wound dressing is likely to increase which will create considerable growth opportunities for the moist wound dressing market in this region during the forecast period.